Targeting enabled homolog with daunorubicin inhibits ERK1/2/c-Fos pathway and suppresses hepatocellular carcinoma progression.
作者信息
Li Zhi-Mei, Liu Guan, Liu Qing-Qing, You Wei-Ming, Zhao Ming-Gao
机构信息
Institute of Medical Research, Northwestern Polytechnical University, Xi'an, Shaanxi, China.
Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
出版信息
Clin Transl Med. 2025 Jun;15(6):e70366. doi: 10.1002/ctm2.70366.
Abstract
摘要
Zotero 插件